Retraction
Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
Paper Information
Record ID:
50712
Author(s):
Journal:
Publication Date:
February 24, 2020
Retraction Date:
January 04, 2024
(1.9 year years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Endocrinology, West China Hospital, Sichuan University Chengdu 610041 Sichuan China
- Department of Endocrinology, Affiliated Hospital of Hubei University for Nationalities Enshi 445000 Hubei China
- China Pharmaceutical University Nanjing Jiangsu P. R. China
- Jiangnan University Wuxi Jiangsu P. R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Royal Society of Chemistry (RSC)
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Author Unresponsive
- Concerns/Issues About Data
- Error in Methods
- Euphemisms for Plagiarism
- Investigation by Journal/Publisher
- Investigation by Third Party
- Original Data and/or Images not Provided and/or not Available
- Plagiarism of Article
- Unreliable Results and/or Conclusions
- Upgrade/Update of Prior Notice(s)
Nature of Retraction:
Retraction
Retraction Notice:
10.1039/d3ra90124fCitations (10)
10
Total Citations0
Post-Retraction9
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice
Sing-Young Chen, Martina Beretta, Ellen M. Olzomer et al. (15 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Oct 2023
3 citations
3 citations
94 days before retraction
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wenwei Wan, Qikai Qin, Linshan Xie et al. (7 authors)
Molecules
Open Access
Published: Jan 2023
25 citations
25 citations
358 days before retraction
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
Diabetes Metabolic Syndrome and Obesity
Open Access
Published: Aug 2021
307 citations
307 citations
886 days before retraction
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Amaara Marzook, Shiqian Chen, Philip Pickford et al. (14 authors)
Biochemical Pharmacology
Open Access
Published: Jun 2021
10 citations
10 citations
936 days before retraction
The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
Amaara Marzook, Alejandra Tomás, Ben Jones
Frontiers in Endocrinology
Open Access
Published: May 2021
78 citations
78 citations
969 days before retraction
The therapeutic potential of GLP‐1 receptor biased agonism
Ben Jones
British Journal of Pharmacology
Open Access
Published: Apr 2021
64 citations
64 citations
988 days before retraction
Evaluation of efficacy- <i>versus</i> affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Amaara Marzook, Shiqian Chen, Philip Pickford et al. (14 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2021
1007 days before retraction
The impact of chemical engineering and technological advances on managing diabetes: present and future concepts
Sabine Szunerits, Sorin Melinte, Alexandre Barras et al. (7 authors)
Chemical Society Reviews
Published: Dec 2020
39 citations
39 citations
1113 days before retraction
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
Zijian Fang, Shiqian Chen, Yusman Manchanda et al. (18 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2020
42 citations
42 citations
1151 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #43553
Nov 15, 2022Quick Stats
Total Citations:
19
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025